Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3004 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

GeNOsys signs service contract with UBC

Under the service contract, the University of British Columbia (UBC) will conduct research at the UBC Department of Medicine, and the Vancouver Coastal Health Research Institute, which conducts

Melior and Pfizer sign option agreement

In exchange, Pfizer has agreed to make an undisclosed payment to Melior and provide access to certain data it owns related to MLR-1023. In addition, Melior has agreed

Invitrogen launches new non-radioactive test kit

Invitrogen’s Predictor hERG fluorescence polarization assay kit is said to be the first commercially available non-radioactive, homogenous assay kit for high-throughput screening of compounds interacting with the hERG

Urologix names new CEO and director

Mr Warren assumes the office from Mitchell Dann who has served as interim CEO since February 2008. Mr Dann continues to serve as chairman and a director. From

Pinnacle signs contract with Chiltern

James Miller, president and CEO of Pinnacle Biologics, said: “The completion of the Chiltern agreement represents a significant step in the process of offering a full range of

Sigma-Aldrich launches new DNA purification kit

According to the company, the new 96-well kit is suitable for a variety of pharmaceutical and biotechnology research applications, providing rapid purification of plasmid DNA that can generate